Drugs / Prebiotin
Prebiotin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03617783 Comparator | Jul 2019 → Apr 2022 | schizoaffective disorder, schizophrenia | University of Maryland, Baltimore | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prebiotin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03617783 ↗ |
| Known as | OEI | “the oligofructose-enriched inulin (OEI) prebiotic: Prebiotin could increase the production of butyrate” PMID 39146178 ↗ Aug 2024 |
| Known as | oligofructose-enriched inulin | “the oligofructose-enriched inulin (OEI) prebiotic: Prebiotin could increase the production of butyrate” PMID 39146178 ↗ Aug 2024 |
| Modality | Other / unclassified | “the prebiotic: Prebiotin (12g/day), an oligofructose-enriched inulin (OEI)” NCT03617783 ↗ |